Government has commissioned external analysis of Brexit impact on UK medicines supply chain, MPs told The government has commissioned an analysis by professional services consultants Ernst and Young into the impact of Brexit on the UK medicines supply chain.…
UK regulator seeks to reassure pharmaceutical industry over Brexit The MHRA has issued a statement emphasising that following Brexit, EU regulation rules will likely continue to apply for the foreseeable future.…
MHRA issues call to remain ‘vigilant’ with commonly confused drug names The Medicines and Healthcare products Regulatory Agency (MHRA) has asked prescribers and dispensers to remain vigilant with “commonly confused” medicines.…
Moving from retail to industry: a letter to all pharmacists Former community pharmacist Vikesh Lad describes his new career at the Medicines and Healthcare products Regulatory Agency.…
EMA draws up plans to move MHRA work Plans are being drawn up to redistribute the European work of the UK’s medicines safety watchdog in the run up to Brexit.…
Drug price manipulations destabilise pharmacy Emerging reports that some smaller pharmaceutical wholesalers and independent pharmacist wholesalers could be manipulating the markets to cause unprecedented drug price rises are deeply concerning.…
Brexit could hinder medicines supply to UK, MPs told Medicines could become more difficult to import into the UK post-Brexit, MP members of the Health Select Committee were told on 5 December 2017…
Sildenafil to be reclassified to P medicine Sildenafil is to be formally reclassified from a prescription only medicine to a pharmacy medicine, the Medicines and Healthcare products Regulatory Agency has announced.…
MHRA launches social media campaign to promote Yellow Card reporting The Medicines and Healthcare products Regulatory Agency has launched a social media campaign to promote the reporting of suspected side effects from over-the-counter medicines…
EMA staff could work remotely from London after move to Amsterdam European Medicines Agency (EMA) staff could remain in London and work remotely for a “transitional” period following the move to Amsterdam, the EMA’s executive director has said.…